These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25544397)

  • 21. Physiologic and pathophysiologic roles of endothelin in the kidney.
    Clavell AL; Burnett JC
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):66-72. PubMed ID: 7850414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin and endothelin receptors in the renal and cardiovascular systems.
    Vignon-Zellweger N; Heiden S; Miyauchi T; Emoto N
    Life Sci; 2012 Oct; 91(13-14):490-500. PubMed ID: 22480517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The paracrine endothelin system: pathophysiology and implications in clinical medicine.
    Hocher B; Thöne-Reineke C; Bauer C; Raschack M; Neumayer HH
    Eur J Clin Chem Clin Biochem; 1997 Mar; 35(3):175-89. PubMed ID: 9127739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin-1 and the kidney: new perspectives and recent findings.
    De Miguel C; Speed JS; Kasztan M; Gohar EY; Pollock DM
    Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):35-41. PubMed ID: 26625864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin and its antagonists in hypertension: can we foresee the future?
    Moreau P; Rabelink TJ
    Curr Hypertens Rep; 1999; 1(1):69-78. PubMed ID: 10981045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin, sex and hypertension.
    Tostes RC; Fortes ZB; Callera GE; Montezano AC; Touyz RM; Webb RC; Carvalho MH
    Clin Sci (Lond); 2008 Jan; 114(2):85-97. PubMed ID: 18062774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endothelin and kidney].
    Dousset B; Jacob C; Huu TC; Kessler M
    Nephrologie; 1993; 14(1):9-17. PubMed ID: 8502348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelins and venous tone in DOCA-salt hypertension.
    van den Meiracker AH
    J Hypertens; 2002 Apr; 20(4):587-9. PubMed ID: 11910286
    [No Abstract]   [Full Text] [Related]  

  • 29. Targets for endothelin in the diseased kidney: clues for therapeutic intervention.
    Rohmeiss P; Birck R; Braun C; Kirchengast M; van der Woude FJ
    Exp Nephrol; 1999; 7(1):1-10. PubMed ID: 9892807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Twelfth International Conference on Endothelin (ET-12), Cambridge 2011.
    Barton M; Davenport AP
    Life Sci; 2012 Oct; 91(13-14):462-5. PubMed ID: 22842028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelin-1 and the pulmonary vascular response to altitude: a new therapeutic target?
    Rubin LJ
    Circulation; 2006 Sep; 114(13):1350-1. PubMed ID: 17000920
    [No Abstract]   [Full Text] [Related]  

  • 32. [Endothelin and essential hypertension].
    Kataoka K; Kurihara Y; Kurihara H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():640-3. PubMed ID: 15506465
    [No Abstract]   [Full Text] [Related]  

  • 33. [Endothelin-1 and cardiovascular diseases].
    Cracowski JL; Stanke F; Bessard G
    Rev Med Interne; 1999 Jul; 20(7):589-96. PubMed ID: 10434349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies.
    Benigni A
    Curr Opin Nephrol Hypertens; 1995 Jul; 4(4):349-53. PubMed ID: 7552102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin Receptor Antagonists: New Hope for Renal Protection?
    Tobe S; Kohan DE; Singarayer R
    Curr Hypertens Rep; 2015 Jul; 17(7):57. PubMed ID: 26068660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin receptor antagonists in clinical research--lessons learned from preclinical and clinical kidney studies.
    Reichetzeder C; Tsuprykov O; Hocher B
    Life Sci; 2014 Nov; 118(2):141-8. PubMed ID: 24607774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Participation of renal and circulating endothelin in salt-sensitive essential hypertension.
    Elijovich F; Laffer CL
    J Hum Hypertens; 2002 Jul; 16(7):459-67. PubMed ID: 12080429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelin in chronic proteinuric kidney disease.
    Gagliardini E; Buelli S; Benigni A
    Contrib Nephrol; 2011; 172():171-184. PubMed ID: 21893998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelin, kidney disease, and hypertension.
    Speed JS; Pollock DM
    Hypertension; 2013 Jun; 61(6):1142-5. PubMed ID: 23608655
    [No Abstract]   [Full Text] [Related]  

  • 40. Endothelin receptor antagonists. Promising new agents in the management of cardiovascular disorders.
    Goddard J; Webb DJ
    Drugs R D; 1999 Jul; 2(1):1-12. PubMed ID: 10560541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.